Patent · US Active

Reagent kit used for detecting lipoprotein-associated phospholipase A2, and preparation method and application for reagent kit

US10451624B2 · kind B2 · utility

0Cited by
2References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 10, 2015
Grant dateOct 22, 2019
Priority date
Expiry dateNov 22, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/918
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A reagent kit used for detecting lipoprotein-associated phospholipase A2, and a preparation method for the reagent kit. The reagent kit comprises one or a plurality of first anti-lipoprotein-associated phospholipase A2 antibodies used for binding lipoprotein-associated phospholipase A2 to be measured, and one or a plurality of second anti-lipoprotein-associated phospholipase A2 antibodies marked with a trace marker and binding with the lipoprotein-associated phospholipase A2 to be measured at another site, different from the binding site of the lipoprotein-associated phospholipase A2 to be measured and the first anti-lipoprotein-associated phospholipase A2 antibodies. The reagent kit also comprises a displacing agent, so as to further increase the detection accuracy of the reagent kit. A method using the reagent kit for the detection of lipoprotein-associated phospholipase A2 may take serum as a detection sample, has high repeatability and high accuracy, and measures the concentration of lipoprotein-associated phospholipase A2 in the sample in a highly sensitive manner.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.